Lipocine (LPCN) Return on Invested Capital (2018 - 2022)

Lipocine (LPCN) has 5 years of Return on Invested Capital data on file, last reported at 0.04% in Q4 2022.

• Quarterly Return on Invested Capital fell 4.0% year-over-year to 0.04% in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.04% (down 4.0% YoY) and the FY2021 annual result came in at 0.01%, up 5.0% from the prior year.
• Return on Invested Capital slipped to 0.04% in Q4 2022, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2022 to a low of 0.08% in Q2 2018.
• A 5-year average of 0.01% and a median of 0.01% in 2020 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2019 — Return on Invested Capital increased 7 bps — and 2022, when it slipped 4 bps.
• Tracing LPCN's Return on Invested Capital over 5 years: stood at 0.01% in 2018, then jumped by 41 bps to 0.01% in 2019, then sank by 77 bps to 0.01% in 2020, then surged by 114 bps to 0.0% in 2021, then slumped by 2035 bps to 0.04% in 2022.
• The last three Return on Invested Capital figures came in at 0.04% (Q4 2022), 0.01% (Q3 2022), and 0.0% (Q2 2022), per Business Quant data.